Free Trial

Acrivon Therapeutics (ACRV) Insider Trading & Ownership

Acrivon Therapeutics logo
$1.90 -0.01 (-0.26%)
As of 01:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Acrivon Therapeutics (NASDAQ:ACRV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.50%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$114.53K
Number Of
Insiders Selling
(Last 12 Months)
0
Get ACRV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACRV Insider Buying and Selling by Quarter

Acrivon Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/14/2026
Adam D Levy
CFO
Buy8,832$1.70$15,014.40  
1/14/2026
Peter Blume-Jensen
CEO
Buy49,000$1.68$82,320.00  
1/13/2026
Eric Devroe
COO
Buy10,000$1.72$17,200.00  
(Data available from 1/1/2013 forward)

ACRV Insider Trading Activity - Frequently Asked Questions

The list of insiders at Acrivon Therapeutics includes Adam D Levy, Eric Devroe, Ltd Chione, Perceptive Advisors Llc, and Peter Blume-Jensen. Learn more on insiders at ACRV.

8.50% of Acrivon Therapeutics stock is owned by insiders. Learn more on ACRV's insider holdings.

The following insiders have purchased ACRV shares in the last 24 months: Adam D Levy ($15,014.40), Eric Devroe ($17,200.00), and Peter Blume-Jensen ($82,320.00).

Insiders have purchased a total of 67,832 ACRV shares in the last 24 months for a total of $114,534.40 bought.

The following insider sold ACRV shares in the last 24 months: Perceptive Advisors Llc ($3,009,858.24).

Insiders have sold a total of 1,707,833 Acrivon Therapeutics shares in the last 24 months for a total of $3,009,858.24 sold.



This page (NASDAQ:ACRV) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners